iness, tingling and
pain). Three double-blind vs placebo RCTs support these
ﬁndings. One304 crossover trial vs placebo, in 71 patients
with CVI Widmer grade I to II, reported a signiﬁcantly
decreased leg circumference (P < .0001) and an
increased cutaneous microvascular blood ﬂow (P <
.0001) as well as transcutaneous oxygen